City State Bank Amgen Inc Transaction History

City State Bank

$272 Million
Q3 2024

A detailed history of City State Bank transactions in Amgen Inc stock. As of the latest transaction made, City State Bank holds 2,390 shares of AMGN stock, worth $619,679. This represents 0.28% of its overall portfolio holdings.

Number of Shares

2,390

Previous 2,415 1.04%

Holding current value

$619,679

Previous $754,000 2.12%

% of portfolio

0.28%

Previous 0.31%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	SELL	$309.38 - $337.38 $7,734 - $8,434	-25 Reduced 1.04%	2,390 $770,000
Q2 2024 Jul 08, 2024	SELL	$262.75 - $319.31 $15,765 - $19,158	-60 Reduced 2.42%	2,415 $755,000
Q1 2024 Apr 11, 2024	SELL	$268.87 - $324.56 $17,207 - $20,771	-64 Reduced 2.52%	2,475 $704,000
Q4 2023 Jan 10, 2024	BUY	$255.7 - $288.46 $3,579 - $4,038	14 Added 0.55%	2,539 $731,000
Q3 2023 Oct 16, 2023	BUY	$218.65 - $271.46 $38,263 - $47,505	175 Added 7.45%	2,525 $679,000
Q2 2023 Jul 10, 2023	SELL	$214.27 - $253.37 $9,427 - $11,148	-44 Reduced 1.84%	2,350 $522,000
Q1 2023 Apr 10, 2023	SELL	$225.79 - $275.2 $7,902 - $9,632	-35 Reduced 1.44%	2,394 $579,000
Q4 2022 Jan 11, 2023	SELL	$229.03 - $291.01 $6,183 - $7,857	-27 Reduced 1.1%	2,429 $638,000
Q3 2022 Oct 24, 2022	SELL	$224.46 - $253.15 $11,223 - $12,657	-50 Reduced 2.0%	2,456 $554,000
Q2 2022 Aug 22, 2022	SELL	$230.71 - $256.74 $2,076 - $2,310	-9 Reduced 0.36%	2,506 $610,000
Q1 2022 Jun 01, 2022	BUY	$219.27 - $242.57 $32,890 - $36,385	150 Added 6.34%	2,515 $608,000
Q4 2021 Mar 23, 2022	SELL	$198.88 - $227.6 $31,820 - $36,416	-160 Reduced 6.34%	2,365 $532,000
Q4 2021 Mar 11, 2022	BUY	$198.88 - $227.6 $502,172 - $574,690	2,525 New	2,525 $588,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $139B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of City State Bank, based on Form 13F filings with the SEC.

News

Stay updated on City State Bank with notifications on news.

Account